potent < potential < potentialities

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 161.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000003 (2016)	Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie]	High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant
000009 (2013)	Richard Pažout ; Jaroslav Maixner ; Michaela Hrdá ; Tereza Loužilová ; Petr Ka Er	A bromine analogue of picoplatin: a new substance from the group of platinum‐based chemotherapeutics
000022 (1993)	Judith R. Sch Ffr [Allemagne] ; Yoshihiro Kawaoka [Allemagne] ; William J. Bean [Allemagne] ; Jochen Süss [Allemagne] ; Dennis Senne [Allemagne] ; Robert G. Webster [Allemagne]	Origin of the Pandemic 1957 H2 Influenza A Virus and the Persistence of Its Possible Progenitors in the Avian Reservoir
000029 (2001)	Suryaprakash Sambhara ; Anjna Kurichh ; Renata Miranda ; Terrence Tumpey ; Thomas Rowe ; Mary Renshaw ; Rita Arpino ; Alan Tamane ; Ali Kandil ; Olive James ; Brian Underdown ; Michel Klein ; Jacqueline Katz ; David Burt	Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T-Lymphocyte and Macrophage Function
000036 (2002)	N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]	Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
000062 (1995)	S. Chatterjee [Inde] ; K. K. Mukherjee [Inde] ; M. C. Mondal [Inde] ; S. K. Chakravarti [Inde] ; M. S. Chakraborty [Inde]	A serological survey of influenza a antibody in human and pig sera in Calcutta
000069 (2012)	H. D. Klenk [Allemagne]	Evolution und Infektionsbiologie neuer Influenza-A-Viren mit pandemischem Potenzial
000093 (1987)	Alan P. Kendal [États-Unis]	Epidemiologic implications of changes in the influenza virus genome
000112 (2001)	L. G Rudenko [Russie] ; G. I Alexandrova [Russie]	Current strategies for the prevention of influenza by the Russian cold-adapted live influenza vaccine among different populations
000137 (1993)	Norman Goldberg [Allemagne] ; Max C. Holthausen [Allemagne] ; Jan Hrušák [Allemagne] ; Wolfram Koch [Allemagne] ; Helmut Schwarz [Allemagne]	Mass‐Spectrometric and GAUSSIAN2 Studies of the Diazene (HNNH) and Isodiazene (H2NN) Molecules and Their Radical Cations
000182 (2001)	D. L Major [Royaume-Uni] ; R. W Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; A. B Heath [Royaume-Uni] ; K. Ploss [Royaume-Uni] ; J. M Wood [Royaume-Uni]	Evaluation of H9N2 influenza vaccines in Balb/c mice
000189 (1989)	John Treanor ; Kawaoka Yoshihiro [États-Unis] ; Roger Miller ; Robert G. Webster [États-Unis] ; Brian Murphy	Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes
000212 (2012)	Cees Bruggink [Pays-Bas] ; Ben J. H. M. Poorthuis [Pays-Bas] ; André M. Deelder [Pays-Bas] ; Manfred Wuhrer [Pays-Bas]	Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography–mass spectrometry
000214 (2004)	Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]	Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
000222 (1994)	Michèle Aymard [France]	Identification of pandemic viral strains
000239 (2010)	I. Bhattacharyya [Inde] ; B. Mondal [Inde] ; A. K. Das [Inde]	Structure, stability and dissociation of silanitriles RSiN (R = H2B, H2N, H2P)
000249 (1999)	J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]	Identification of a novel HA conformational change inhibitor of human influenza virus
000269 (2009)	M. Michaelis [Allemagne] ; H. W. Doerr [Allemagne] ; J. Cinatl Jr [Allemagne]	An influenza A H1N1 virus revival – pandemic H1N1/09 virus
000289 (2000)	Eric C. J Claas [Pays-Bas]	Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population
000301 (1970)		Mass-velocity correction to the solution of the Schrodinger equation for the Mathieu potential
000317 (2012)	Lanying Du [États-Unis] ; Ye Li [États-Unis, République populaire de Chine] ; Jimin Gao [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Shibo Jiang [États-Unis, République populaire de Chine]	Potential strategies and biosafety protocols used for dual‐use research on highly pathogenic influenza viruses

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "potential" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "potential" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    potential
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021